Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2007
11/28/2007EP1858519A2 Orally used compatible solute containing agents
11/28/2007EP1858503A1 Topical gels compositions
11/28/2007EP1545620B1 Pharmaceutical compositions comprising cyclosporin for oral administration
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007EP1328245B1 Dental care compositions
11/28/2007EP1315718B1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/28/2007CN101077867A Bis-aryl sulfonamides
11/28/2007CN101077865A Phthalazines derivatives, preparation method thereof, medicament composition and use
11/28/2007CN101077403A Plaster for treating retention of food and dysmenorrhea
11/28/2007CN101077393A Shoushen shenbao' granule
11/28/2007CN101077375A External application pain-relieving anti-inflammation traditional Chinese medicine for treating injuries from falls and rheumatisants
11/28/2007CN101077371A Method for treating wind-cold common cold
11/28/2007CN101077361A External applied Traditional Chinese medicine powder medicine for dewatering, anti-inflammation and pain-relieving
11/28/2007CN101077344A Infusion preparation of ibuprofen and preparation method thereof
11/28/2007CN101077343A Dexibuprofen granule and preparation method thereof
11/28/2007CN101077339A Dexibuprofen effervescent tablet and preparation method thereof
11/28/2007CN101077336A Injection containing ketoprofen and preparation method thereof
11/28/2007CN101077212A Multi-flavor vision-improving beverage
11/28/2007CN101077185A Natural plant health-care cold tea and its preparing process
11/28/2007CN101077183A Novel capilary artemisia red date composite health care beverage and its processing technology
11/28/2007CN101077175A Three kinds of seed health care tea soup
11/28/2007CN101077165A 枇杷罐头 Canned loquat
11/28/2007CN101077112A 板蓝根茶及其制备方法 Radix tea and its preparation method
11/28/2007CN101077111A Agastache mate tea
11/28/2007CN101077110A Health-care tea and its making method
11/28/2007CN101077103A Inflammation-diminishing and cough-controlling tea
11/28/2007CN101077099A Detumescence and throat-clearing tea
11/28/2007CN100351261C Crystalline glucosamine sulphate metal salts and its preparation method
11/28/2007CN100351259C Sulfur-containing phospholipid derivatives
11/28/2007CN100351253C Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents
11/28/2007CN100351251C Indolylmaleimide derivatives
11/28/2007CN100351245C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/28/2007CN100351244C Bis-aromatic alkanols
11/28/2007CN100351239C Pyrimidine derivatives and their use as CB2 modulators
11/28/2007CN100351237C Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine
11/28/2007CN100350973C Drug composition for curing disease produced from IL-6
11/28/2007CN100350963C Compound saffron oil and its production technology
11/28/2007CN100350953C Medicinal composition for treating high fever due to virus infection and its preparation method
11/28/2007CN100350935C Medicine composition for treating rheumatoid arthritis and rheumatism
11/28/2007CN100350922C Preparing anti-inflammatory component of bighead atractylodes rhizome volatile oil part and use in preparing anti-inflammatory medicines
11/28/2007CN100350914C Medicinal composition for antipyretic, analgesic, anti-inflammatory and anti platelet aggregation
11/28/2007CN100350913C Colonic release composition
11/28/2007CN100350906C Dichlofenas sodium slow release suppository and its preparation method
11/27/2007US7301028 Mitotic kinesin inhibitors
11/27/2007US7301023 Immunosuppressants; grafting of organs; rheumatic diseases
11/27/2007US7301005 Immunomodulatory peptides derived from heat shock proteins and uses thereof
11/27/2007US7300952 NF-κb inhibitors
11/27/2007US7300925 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3
11/27/2007US7300917 Remedy for chronic disease
11/27/2007US7300916 Use of an erythropoietin antagonist for manufacture of a pharmaceutical preparation for preventing and/or treating hypertrophic scars, keloid or chronic arthritic diseases.
11/27/2007US7300670 Oral suspension formulation
11/27/2007US7300662 Local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography, lower systemic toxicity
11/27/2007CA2379695C Compounds for modulating the rage receptor
11/27/2007CA2338896C Fast dissolving ibuprofen containing compositions having analgesic activity
11/27/2007CA2290557C Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
11/27/2007CA2271683C Coated particles, methods of making and using
11/22/2007WO2007132948A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132945A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132893A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor
11/22/2007WO2007132846A1 Compound having acidic group which may be protected, and use thereof
11/22/2007WO2007132825A1 Pharmaceutical agent
11/22/2007WO2007132280A1 Isatin and its derivatives for use as a medicament
11/22/2007WO2007132037A1 Method for synthesizing thymosins
11/22/2007WO2007131764A2 New heterocyclic compounds for the inhibition of integrins and use thereof
11/22/2007WO2007131310A1 Anti-inflammatory and analgesic pharmaceutical composition containing safrole n-acylhydrazone derivatives, use, and method of preparation
11/22/2007WO2007131286A1 Nanostructures suitable for delivery of agents
11/22/2007WO2007131253A2 Use of combination preparations comprising antifungal agents
11/22/2007WO2007108004A8 S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
11/22/2007WO2007107663A3 Use of (3s)-n-hydroxy-4-({4-[(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide or (s)-n-hydroxy-4-(4-but-2-ynyloxy-benzenesulfonyl) -2,2-dimethyl-thiomorpholine -3-carboxamide for treating inflammatory skin pathologies
11/22/2007WO2007107161A8 Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis
11/22/2007WO2007093183A3 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
11/22/2007WO2007057221A3 Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases
11/22/2007WO2006129158A3 3 - indazolyl - isoxazoline derivatives as inhibitors of phosphodiesterase type - i
11/22/2007WO2006057886A8 2-METHYLENE-19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND ITS USES
11/22/2007US20070270476 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
11/22/2007US20070270469 e.g. 4-(5-{(1R)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,4-triazol-3-yl)pyridine hydrochloride; glutamate mGluR5 receptor modulator; antidepressant, anxiolytic, analgesic agent; neurodegenerative disorder
11/22/2007US20070270468 e.g. 4-(5-{(1R)-1-[5-(3-chlorophenyl)isoxazol-3-yl]ethoxy}-4-methyl-4H-1,2,4-triazol-3-yl)pyridine hydrochloride; glutamate mGluR5 receptor modulator; antidepressant, anxiolytic, analgesic agent; neurodegenerative disorder
11/22/2007US20070270441 Combination
11/22/2007US20070270439 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents
11/22/2007US20070270435 Novel Compounds
11/22/2007US20070270419 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
11/22/2007US20070270418 Inhibitors of P38 and Methods of Using the Same
11/22/2007US20070270410 N3-[4-(4-Morpholin-4-yl-cyclohexyl)-phenyl]-1-pyridin-2-yl-1H-[1,2,4]triazole-3,5-diamine; antiproliferative agent; Alzheimer's Disease; Multiple Sclerosis Parkinson's Disease, asthma, schizophrenia, anti-nflammatory agent; cardiovascular disease; bone disorders
11/22/2007US20070270395 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 2-Cyclopropylmethoxy-4-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-quinoline-3-carbonitrile; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
11/22/2007US20070270392 Use of a Cyclopentenone Prostaglandin for Delaying the Onset and/or Preventing the Continuation of Labour
11/22/2007US20070270375 Obtained from plants of Barringtonia species which are derived from Barringtoside A and Barringtoside C as precursor compounds which especially have an arabinopyranosyl substituent at 21 position, which may optionally be further substituted with benzoyl, dibenzoyl, methyl butanoyl, at 3 or 4 position
11/22/2007US20070270337 Pharmaceutical Compositions for Preventing or Treating Th1-Mediated Immune Diseases
11/22/2007US20070270334 Polypeptide-dimers for use in treatment and prevention of infection, bone, blood, eating, tumor, autoimmune and inflammatory disorders
11/22/2007US20070269847 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/22/2007US20070269507 Pharmaceutical Composition
11/22/2007US20070269437 Pro-Inflammatory and Anti-Inflammatory Antibodies Against the Heparin-Binding Protein (Hbp)
11/22/2007US20070269421 Diagnostics and Therapeutics for Diseases Associated with Plasma Glutamate Carboxypeptidase (Pgcp)
11/22/2007US20070269374 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction
11/22/2007DE102006023337A1 Triazolderivate II Triazole derivatives II
11/22/2007DE102006023336A1 1,5-Diphenyl-pyrazole II 1,5-diphenyl-pyrazoles II
11/22/2007CA2652101A1 New heterocyclic compounds for the inhibition of integrins and use thereof
11/22/2007CA2651726A1 Use of combination preparations, comprising antimycotics
11/22/2007CA2633439A1 Methods of treating pain and inflammation in neuronal tissue using il-31ra and osmrb antagonists
11/21/2007EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
1 ... 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 ... 1272